Panama - inglese - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

shandong luoxin pharmaceutical group stock co.,ltd - cefepime - cefepime....1.0 g

Malesia - inglese - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

aft pharmaceuticals (se asia) sdn bhd - cefepime hydrochloride monohydrate -

Stati Uniti - inglese - NLM (National Library of Medicine)

hospira, inc. - cefepime hydrochloride (unii: i8x1o0607p) (cefepime - unii:807pw4vqe3) - cefepime 1 g - maxipime is indicated in the treatment of pneumonia (moderate to severe) caused by susceptible strains of streptococcus pneumoniae , including cases associated with concurrent bacteremia, pseudomonas aeruginosa , klebsiella pneumoniae , or enterobacter species. maxipime as monotherapy is indicated for empiric treatment of febrile neutropenic patients. in patients at high risk for severe infection (including patients with a history of recent bone marrow transplantation, with hypotension at presentation, with an underlying hematologic malignancy, or with severe or prolonged neutropenia), antimicrobial monotherapy may not be appropriate. insufficient data exist to support the efficacy of cefepime monotherapy in such patients [see clinical studies (14.1) ]. maxipime is indicated in the treatment of uncomplicated and complicated urinary tract infections (including pyelonephritis) caused by susceptible isolates of escherichia coli or klebsiella pneumoniae , when the infection is severe, or caused by escherichia c

Australia - inglese - Department of Health (Therapeutic Goods Administration)

omegapharm - cefepime -

Malta - inglese - Malta Medicines Authority

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - powder for solution for injection/infusion - cefepime 1 g - antibacterials for systemic use

Malta - inglese - Malta Medicines Authority

apta medica internacional d.o.o likozarjeva ulica 6, 1000 ljubljana, , slovenia - powder for solution for injection/infusion - cefepime 2 g - antibacterials for systemic use

Australia - inglese - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - cefepime, quantity: 1000 mg - injection, powder for - excipient ingredients: arginine - adults: cefepime is indicated in the treatment of the infections listed below when caused by susceptible bacteria.. - lower respiratory tract infections, including pneumonia and bronchitis. - urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. - skin and skin structure infections. intra-abdominal infections, including peritonitis and biliary tract infections. - gynaecological infections. septicaemia. - empirical treatment in febrile neutropenic patients (see precautions). cefepime is also indicated for surgical prophylaxis in patients undergoing intra-abdominal surgery. in this indication it is essential that metronidazole also be administered. paediatrics: cefepime is indicated in paediatric patients over 2 months of age for the treatment of the infections listed below when caused by susceptible bacteria. pneumonia. - urinary tract infections, both complicated, including pyelonephritis, and uncomplicated infections. - skin and skin structure infections. - septicaemia. - empirical treatment in febrile neutropenic patients (see precautions). culture and susceptibility studies should be performed when appropriate to determine susceptibility of the causative organism(s) to cefepime. empirical therapy with cefepime may be instituted before results of susceptibility studies are known; however, once these results become available, the antibiotic treatment should be adjusted accordingly. because of its broad spectrum of bactericidal activity against gram positive and gram negative bacteria, cefepime can be used appropriately as monotherapy prior to identification of the causative organisms(s). in the treatment of febrile neutropenia, consideration should be given to the need for other antibiotics in combination with cefepime. in patients who are at risk of mixed aerobic/ anaerobic infection, including infections in which bacterioides fragilis may be present, concurrent initial therapy with an antianaerobic agent is recommended before the causative organism(s) is known.

Namibia - inglese - Namibia Medicines Regulatory Council

aurobindo pharma (pty) ltd - cefepime hydrochloride - injection - each vial contains cefepime hydrochloride equivalent to cefepime 500,0 mg

Namibia - inglese - Namibia Medicines Regulatory Council

aurobindo pharma (pty) ltd - cefepime hydrochloride - injection - each vial contains cefepime hydrochloride equivalent to cefepime 1000,0 mg

Namibia - inglese - Namibia Medicines Regulatory Council

aurobindo pharma (pty) ltd - cefepime hydrochloride - injection - each vial contains cefepime hydrochloride equivalent to cefepime 2000,0 mg